{"organizations": [], "uuid": "1924f8f20a65134bf89648a1a6fcb8d3b8233f56", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ucb-to-present-phase-2b-findings-f/brief-ucb-to-present-phase-2b-findings-for-bimekizumab-idUSFWN1Q61BK", "country": "US", "domain_rank": 408, "title": "BRIEF-UCB To Present Phase 2b Findings For Bimekizumab", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-16T17:40:00.000+02:00", "replies_count": 0, "uuid": "1924f8f20a65134bf89648a1a6fcb8d3b8233f56"}, "author": "", "url": "https://www.reuters.com/article/brief-ucb-to-present-phase-2b-findings-f/brief-ucb-to-present-phase-2b-findings-for-bimekizumab-idUSFWN1Q61BK", "ord_in_thread": 0, "title": "BRIEF-UCB To Present Phase 2b Findings For Bimekizumab", "locations": [], "entities": {"persons": [{"name": "min rea", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "bimekizumab reuters staff", "sentiment": "negative"}, {"name": "ucb sa", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 41 PM / in 5 minutes BRIEF-UCB To Present Phase 2b Findings For Bimekizumab Reuters Staff 1 Min Read Feb 16 (Reuters) - Ucb Sa: * UCB ADVANCES PSORIASIS PIPELINE WITH POSITIVE DATA AT AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD 2018) * FULL EFFICACY AND SAFETY FINDINGS FROM PHASE 2B BE ABLE STUDY ON INVESTIGATIONAL MOLECULE BIMEKIZUMAB WILL HIGHLIGHT DUAL NEUTRALIZATION OF IL-17A AND IL-17F Source text for Eikon: Further company coverage: (Gdynia Newsroom:)", "external_links": [], "published": "2018-02-16T17:40:00.000+02:00", "crawled": "2018-02-16T17:56:16.008+02:00", "highlightTitle": ""}